Medicare Advantage Adverse Participation Decisions and Appeals

"Adverse participation decision" is a federal term with a narrower meaning than most providers expect. In Medicare Advantage, it covers decisions by a plan that hurt a physician's participation: a denial of participation, a suspension, a termination or a nonrenewal. The rights that follow depend on which of those happened, and the plan's letter does not always say. Sorting that out first saves weeks of writing to the wrong office about the wrong rule.

The rules live in 42 CFR 422.202 and are explained in Chapter 6 of CMS's Medicare Managed Care Manual. They apply to MA organizations that operate a coordinated care plan or a network MSA plan, which covers the HMOs and PPOs most providers deal with.

What does federal law require for every adverse decision?

An MA organization must provide for physician participation "through reasonable procedures that include" four things (42 CFR 422.202(a)):

1. Written notice of the rules of participation, "including terms of payment, credentialing, and other rules directly related to participation decisions."
2. Written notice of material changes in those rules before the changes take effect.
3. "Written notice of participation decisions that are adverse to physicians."
4. "A process for appealing adverse participation procedures, including the right of physicians to present information and their views on the decision."

The fourth item adds that in a termination or suspension, the process "must conform to the rules in § 422.202(d)." Separately, any time a plan "declines to include a given provider or group of providers in its network," it must give written notice of the reason (42 CFR 422.205(a)). The rules reach physicians inside subcontracted groups too: a plan that works through subcontracted physician groups must make these participation procedures "apply equally to physicians within those subcontracted groups" (422.202(c)).

How do terminations and suspensions differ from a first-time denial?

For a suspension or termination, 422.202(d) adds specific protections. The plan must give the physician written notice of:

• "The reasons for the action, including, if relevant, the standards and profiling data used to evaluate the physician and the numbers and mix of physicians needed by the MA organization."
• "The affected physician's right to appeal the action and the process and timing for requesting a hearing."

The plan "must ensure that the majority of the hearing panel members are peers of the affected physician" (422.202(d)(2)). Both sides must give "at least 60 days written notice to each other before terminating the contract without cause" (422.202(d)(4)). And if the plan acts because of quality of care deficiencies, it must report the action to licensing or disciplinary bodies (422.202(d)(3)), which is a reason to take any quality-based notice seriously from the first day.

CMS's manual extends this. Section 60.4 states that the preamble to the February 17, 1999 final rule applied the notice and appeal requirements "regardless of whether suspension or termination of the physician contract is due to quality deficiencies or not, unless the physician voluntarily agreed to leave the organization's network," and "clarified that these requirements apply to nonrenewal of contracts."

A first-time applicant does not get the 422.202(d) hearing. The guaranteed right is the written reason, and CMS's manual places the appeal process for adverse participation decisions under the termination section. Some plans give applicants a reconsideration anyway, especially for credentialing denials. Ask for the plan's written procedure; do not assume a hearing exists.

Which kind of decision did you get?

Read the letter for these signals:

• "Not accepting applications," "network need," "adequate network." A contracting decision on network size, allowed under 422.205(b)(1). The remedy is the written reason and the plan's network data, not a hearing.
• "Did not meet credentialing criteria," "committee decision." A credentialing denial. Ask for the criteria, the file items relied on and any reconsideration window. See credentialing committee adverse decisions.
• "Terminate," "suspend," "will not renew." The 422.202(d) protections and the manual's nonrenewal guidance apply. Note every date in the letter.
• Excluded, precluded or opted out. Plans must comply with the exclusion and opt-out rules and the preclusion list (422.204(b)(4) and (c)). No plan appeal fixes those; the status itself has to change.

What should a response to an adverse decision contain?

The appeal right in 422.202(a)(4) is a right "to present information and their views on the decision." That shapes the response. A useful packet usually has:

• A short cover letter naming the decision, its date and the procedure you are using.
• Corrections to any factual error, with documents: license verifications, malpractice certificates, hospital privilege letters, board certification.
• For a profiling-based termination, a request for the "standards and profiling data used" and a response to them, including case mix.
• For a decision tied to network size, the access facts: whether your specialty is one of the 42 CFR 422.116 types, how many members you already see, wait times in your area and distance to the nearest in-network alternative.

Keep it factual and specific. A hearing panel of peers responds to clinical and operational facts, not to adjectives. If the stakes include a report to your licensing board, a contract dispute or a hearing where you want someone to speak for you, that is the point to bring in a healthcare attorney you hire directly.

When do the clocks start?

Federal rules fix the 60-day notice for a without-cause termination, but the deadline to request a hearing or reconsideration comes from the plan's notice and its procedures, which 422.202(d)(1)(ii) requires the plan to state. Calendar it the day the letter arrives. Many plans also apply a waiting period before you can reapply after a denial; read the letter and the provider manual for it. Our posts on without-cause terminations, recredentialing denials and reconsideration deadlines go further.

Who decides whether the plan followed the rules?

The plan's own process comes first, and its result is the plan's call. CMS oversees MA organizations under their contracts, but the regulations do not create a separate CMS appeal for an individual provider's participation decision. That makes the record you build inside the plan's process the record that matters. State insurance departments are generally not the forum either: CMS's manual notes that state laws "relating to inclusion or treatment of providers are specifically superseded by Federal law" for MA (Chapter 6, Section 10).

How we help with an MA adverse decision

We research, prepare and organize. We are not a law firm, and we do not represent providers at hearings or give legal advice. Our Network Rejection Review ($249, credited toward a dispute) identifies which kind of decision you received, which rights attach and every deadline in play. A Payer Network Dispute ($799 per payer) covers the records request, the written response and the supporting evidence, prepared for you to sign and send. We track the plan's replies. If the plan reverses course with a contract or a credentialing approval, the win fee is a flat $1,500. For a termination hearing, a healthcare attorney is the right call, and we will say so on the review. The closed panels hub covers the other plan types.